Guardian Pharmacy Services, Inc. (GRDN): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$95.04M
Year ended 2025-12-31
$108.80M
Trailing 12 months to 2026-06-30
2024-12-31: -$43.15M2025-12-31: $95.04M$95.04M
2024-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$95.04Mn/m2026-03-11, From 2025-01-01
2024-12-31-$43.15Mn/a2026-03-11, From 2024-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Retail-Drug Stores and Proprietary Stores), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Guardian Pharmacy Services, Inc. (GRDN)2025-12-31$95.04Mn/m
PetMed Express Inc (PETS)2026-03-31-$49.29Mn/m
Ridgetech Inc. (RDGT)2026-03-31-$1.50Mn/m
CVS Health Corp (CVS)2025-12-31$9.27B-29.3%

Compare GRDN, PETS, RDGT, CVS side by side · Screen every company in Retail-Drug Stores and Proprietary Stores ↗